Rheumatoid Arthritis Panel with Reflex to Rheumatoid Factors, IgA, IgG, and IgM by ELISA

3004056
copy
 

Copy Utility


emailprint
Example Reports
Negative
Positive

Ordering Recommendation

If anticyclic citrullinated peptide (anti-CCP) IgG or rheumatoid factor is positive, rheumatoid factors, IgA, IgG, and IgM will be performed, which may aid in prognostication. Rheumatoid Arthritis Panel (3004055) is preferred for initial workup of suspected rheumatoid arthritis or undifferentiated inflammatory arthritides.

Mnemonic

RA PANEL R

Methodology

Semi-Quantitative Enzyme-Linked Immunosorbent Assay/Quantitative Immunoturbidimetry

Performed

Sun-Sat

Reported

1-4 days

New York DOH Approval Status

This test is New York DOH approved.

Specimen Required

Patient Preparation

Fasting specimen preferred.

Collect

Serum separator tube (SST).

Specimen Preparation

Allow serum to clot completely at room temperature before centrifuging. Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.8 mL) Serum is the only acceptable specimen type for this test without a disclaimer.

Storage/Transport Temperature

Refrigerated.

Unacceptable Conditions

Contaminated, heat-inactivated, hemolyzed, icteric, or severely lipemic specimens.

Remarks
Stability

After separation from cells: Ambient: 24 hours; Refrigerated: 1 week; Frozen: 1 month (should not be thawed more than once)

Reference Interval

Test Number
 Components
 Reference Interval
  Rheumatoid Factor 0-14 IU/mL
  Cyclic Citrullinated Peptide Ab, IgG 0-19 Units
  Carbamylated Protein Antibody, IgG 0-19 Units

Interpretive Data

Anticyclic citrullinated peptide (anti-CCP) IgG antibodies are present in about 69-83 percent of patients with rheumatoid arthritis (RA) and have specificities of 93-95 percent. Anticarbamylated protein (anti-CarP) IgG antibodies are present in about 34-53 percent of patients with RA, have specificities of greater than 90 percent and can occur in RA patients seronegative for both rheumatoid factor and anti-CCP. Anti-CCP and anti-CarP autoantibodies may be present in the preclinical phase of disease, are associated with future RA development, and may predict radiographic joint destruction. Patients with weak positive results should be monitored and testing repeated.

This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.


Component Interpretation
Cyclic Citrullinated Peptide (CCP) Antibody, IgG 19 Units or less
20-39 Units
40-59 Units
60 Units or Greater		 Negative
Weak positive
Moderate positive
Strong positive

Compliance Category

Analyte Specific Reagent (ASR)

Note

If CCP IgG is 20 units or greater and/or rheumatoid factor is 15 IU/mL or greater, then Rheumatoid Factor, IgG/IgM/IgA by EIA will be performed. Additional charges apply.

Hotline History

View Hotline History

 

Hotline History

Date of Change
Test Name Change
Methodology
Performance/Reported Schedule
Specimen Requirements
Reference Interval
Interpretive Data
Note
CPT Code
Component Change
Other Interface Change
New Test
Inactive
08/16/2021
X
N/A

CPT Codes

86200; 86431; 83516 if reflexed, add 83516 x3

Are you an ARUP Client? Click here for your pricing.

Components

Component Test Code* Component Chart Name LOINC
0050465 Rheumatoid Factor 11572-5
0055256 Cyclic Citrullinated Peptide Ab, IgG 33935-8
3003993 Carbamylated Protein Antibody, IgG
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • Carbamylated Protein IgG
  • CarP IgG
  • CCP and RF IgA IgG IgM
  • CCP, RF, RF isotypes
  • RA
  • RA panel reflex RF
  • RF
Rheumatoid Arthritis Panel with Reflex to Rheumatoid Factors, IgA, IgG, and IgM by ELISA